Unknown

Dataset Information

0

Lectin-like transcript 1 is a marker of germinal center-derived B-cell non-Hodgkin's lymphomas dampening natural killer cell functions.

ABSTRACT: Non-Hodgkin's lymphomas (NHLs) are malignant neoplasms which are clinically and biologically diverse. Their incidence is constantly increasing and despite treatment advances, there is a need for novel targeted therapies. Here, we identified Lectin-like transcript 1 (LLT1) as a biomarker of germinal center (GC)-derived B-cell NHLs. LLT1 identifies GC B cells in reactive tonsils and lymph nodes and its expression is maintained in B-cell NHLs which derive from GC, including Burkitt lymphoma (BL), follicular lymphoma (FL), and GC-derived diffuse large B-cell lymphoma (DLBCL). We further show that LLT1 expression by tumors dampens natural killer (NK) cell functions following interaction with its receptor CD161, uncovering a potential immune escape mechanism. Our results pinpoint LLT1 as a novel biomarker of GC-derived B-cell NHLs and as a candidate target for innovative immunotherapies.

SUBMITTER: Germain C 

PROVIDER: S-EPMC4570132 | biostudies-literature | 2015 Aug

REPOSITORIES: biostudies-literature

Json Xml
altmetric image

Publications

Non-Hodgkin's lymphomas (NHLs) are malignant neoplasms which are clinically and biologically diverse. Their incidence is constantly increasing and despite treatment advances, there is a need for novel targeted therapies. Here, we identified Lectin-like transcript 1 (LLT1) as a biomarker of germinal center (GC)-derived B-cell NHLs. LLT1 identifies GC B cells in reactive tonsils and lymph nodes and its expression is maintained in B-cell NHLs which derive from GC, including Burkitt lymphoma (BL), f  ...[more]

Similar Datasets

Unknown Mouse Models of Germinal Center Derived B-Cell Lymphomas.
| S-EPMC8387591 | biostudies-literature
Unknown KLHL6 Is Preferentially Expressed in Germinal Center-Derived B-Cell Lymphomas.
| S-EPMC6279122 | biostudies-literature
Unknown Profiling of Hodgkin's lymphoma cell line L1236 and germinal center B cells: identification of Hodgkin's lymphoma-specific genes.
| S-EPMC1430727 | biostudies-literature
Unknown Mass cytometry defines distinct immune profile in germinal center B-cell lymphomas.
| S-EPMC7764565 | biostudies-literature
Unknown Mutation of chromatin modifiers; an emerging hallmark of germinal center B-cell lymphomas.
| S-EPMC4635197 | biostudies-other
Unknown Common germinal-center B-cell origin of the malignant cells in two composite lymphomas, involving classical Hodgkin's disease and either follicular lymphoma or B-CLL.
| S-EPMC1950043 | biostudies-other
Unknown EZH2 codon 641 mutations are common in BCL2-rearranged germinal center B cell lymphomas.
| S-EPMC3237460 | biostudies-literature
Unknown Mutational mechanisms shaping the coding and noncoding genome of germinal center derived B-cell lymphomas.
| S-EPMC8257491 | biostudies-literature
Unknown Abemaciclib, a CDK4/6 inhibitor, exerts preclinical activity against aggressive germinal center-derived B-cell lymphomas.
| S-EPMC7004541 | biostudies-literature
Unknown Investigation of potential traces of pluripotency in germinal-center-derived B-cell lymphomas driven by MYC.
| S-EPMC4476019 | biostudies-literature